Literature DB >> 19653094

Expression of transforming growth factor-beta receptors in meningeal fibroblasts of the injured mouse brain.

Yukari Komuta1, Xichuan Teng, Hiroko Yanagisawa, Kazunori Sango, Koki Kawamura, Hitoshi Kawano.   

Abstract

The fibrotic scar which is formed after traumatic damage of the central nervous system (CNS) is considered as a major impediment for axonal regeneration. In the process of the fibrotic scar formation, meningeal fibroblasts invade and proliferate in the lesion site to secrete extracellular matrix proteins, such as collagen and laminin. Thereafter, end feet of reactive astrocytes elaborate a glia limitans surrounding the fibrotic scar. Transforming growth factor-beta1 (TGF-beta1), a potent scar-inducing factor, which is upregulated after CNS injury, has been implicated in the formation of the fibrotic scar and glia limitans. In the present study, expression of receptors to TGF-beta1 was examined by in situ hybridization histochemistry in transcortical knife lesions of the striatum in the mouse brain in combination with immunofluorescent staining for fibroblasts and astrocytes. Type I and type II TGF-beta receptor mRNAs were barely detected in the intact brain and first found in meningeal cells near the lesion 1 day postinjury. Many cells expressing TGF-beta receptors were found around the lesion site 3 days postinjury, and some of them were immunoreactive for fibronectin. After 5 days postinjury, many fibroblasts migrated from the meninges to the lesion site formed the fibrotic scar, and most of them expressed TGF-beta receptors. In contrast, few of reactive astrocytes expressed the receptors throughout the postinjury period examined. These results indicate that meningeal fibroblasts not reactive astrocytes are a major target of TGF-beta1 that is upregulated after CNS injury.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19653094     DOI: 10.1007/s10571-009-9435-x

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  39 in total

Review 1.  Functions of transforming growth factor-beta isoforms in the nervous system. Cues based on localization and experimental in vitro and in vivo evidence.

Authors:  K Unsicker; J Strelau
Journal:  Eur J Biochem       Date:  2000-12

2.  Inhibition of collagen synthesis overrides the age-related failure of regeneration of nigrostriatal dopaminergic axons.

Authors:  Hitoshi Kawano; Hong-Peng Li; Kazunori Sango; Koki Kawamura; Geoffrey Raisman
Journal:  J Neurosci Res       Date:  2005-04-15       Impact factor: 4.164

3.  Collagen matrix in spinal cord injury.

Authors:  Nicole Klapka; Hans Werner Müller
Journal:  J Neurotrauma       Date:  2006 Mar-Apr       Impact factor: 5.269

4.  Suppression of fibrous scarring in spinal cord injury of rat promotes long-distance regeneration of corticospinal tract axons, rescue of primary motoneurons in somatosensory cortex and significant functional recovery.

Authors:  Nicole Klapka; Susanne Hermanns; Guido Straten; Carmen Masanneck; Simone Duis; Frank P T Hamers; Daniela Müller; Werner Zuschratter; Hans Werner Müller
Journal:  Eur J Neurosci       Date:  2005-12       Impact factor: 3.386

5.  The response of the cerebral hemisphere of the rat to injury. I. The mature rat.

Authors:  W L Maxwell; R Follows; D E Ashhurst; M Berry
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1990-06-26       Impact factor: 6.237

6.  Expression of pro-inflammatory cytokine and chemokine mRNA upon experimental spinal cord injury in mouse: an in situ hybridization study.

Authors:  D Bartholdi; M E Schwab
Journal:  Eur J Neurosci       Date:  1997-07       Impact factor: 3.386

7.  Signaling activity of homologous and heterologous transforming growth factor-beta receptor kinase complexes.

Authors:  D Vivien; L Attisano; J L Wrana; J Massagué
Journal:  J Biol Chem       Date:  1995-03-31       Impact factor: 5.157

8.  Localization of transforming growth factor-beta1 and receptor mRNA after experimental spinal cord injury.

Authors:  D M McTigue; P G Popovich; T E Morgan; B T Stokes
Journal:  Exp Neurol       Date:  2000-05       Impact factor: 5.330

9.  Expression of transforming growth factor (TGF)-beta1, -beta2, and -beta3 isoforms and TGF-beta type I and type II receptors in multiple sclerosis lesions and human adult astrocyte cultures.

Authors:  C J De Groot; L Montagne; A D Barten; P Sminia; P Van Der Valk
Journal:  J Neuropathol Exp Neurol       Date:  1999-02       Impact factor: 3.685

10.  Effects of transforming growth factor beta 1 on scar production in the injured central nervous system of the rat.

Authors:  A Logan; M Berry; A M Gonzalez; S A Frautschy; M B Sporn; A Baird
Journal:  Eur J Neurosci       Date:  1994-03-01       Impact factor: 3.386

View more
  25 in total

1.  The fibroblast-derived protein PI16 controls neuropathic pain.

Authors:  Pooja Singhmar; Ronnie The Phong Trinh; Jiacheng Ma; XiaoJiao Huo; Bo Peng; Cobi J Heijnen; Annemieke Kavelaars
Journal:  Proc Natl Acad Sci U S A       Date:  2020-02-20       Impact factor: 11.205

2.  Roles of chondroitin sulfate and dermatan sulfate in the formation of a lesion scar and axonal regeneration after traumatic injury of the mouse brain.

Authors:  Hong-Peng Li; Yukari Komuta; Junko Kimura-Kuroda; Toin H van Kuppevelt; Hitoshi Kawano
Journal:  J Neurotrauma       Date:  2013-02-25       Impact factor: 5.269

3.  Meninges: from protective membrane to stem cell niche.

Authors:  Ilaria Decimo; Guido Fumagalli; Valeria Berton; Mauro Krampera; Francesco Bifari
Journal:  Am J Stem Cells       Date:  2012-05-28

Review 4.  Scar-modulating treatments for central nervous system injury.

Authors:  Dingding Shen; Xiaodong Wang; Xiaosong Gu
Journal:  Neurosci Bull       Date:  2014-06-24       Impact factor: 5.203

5.  RNAi-mediated ephrin-B2 silencing attenuates astroglial-fibrotic scar formation and improves spinal cord axon growth.

Authors:  Yi Li; Ying Chen; Ling Tan; Jing-Ying Pan; Wei-Wei Lin; Jian Wu; Wen Hu; Xue Chen; Xiao-Dong Wang
Journal:  CNS Neurosci Ther       Date:  2017-08-21       Impact factor: 5.243

6.  Inhibition of transforming growth factor-β attenuates brain injury and neurological deficits in a rat model of germinal matrix hemorrhage.

Authors:  Anatol Manaenko; Tim Lekic; Margaret Barnhart; Richard Hartman; John H Zhang
Journal:  Stroke       Date:  2014-01-14       Impact factor: 7.914

7.  T-cell factor (TCF/LEF1) binding elements (TBEs) of FasL (Fas ligand or CD95 ligand) bind and cluster Fas (CD95) and form complexes with the TCF-4 and b-catenin transcription factors in vitro and in vivo which result in triggering cell death and/or cell activation.

Authors:  Xia Liu; Yuwei Huang; Yuanyuan Zhang; Xiaohong Li; Chun Liu; Shen Huang; Dezhi Xu; Yang Wu; Xiaojuan Liu
Journal:  Cell Mol Neurobiol       Date:  2016-04-18       Impact factor: 5.046

8.  Altered Sodium and Potassium, but not Calcium Currents in Cerebellar Granule Cells in an In Vitro Model of Neuronal Injury.

Authors:  Katarína Ondáčová; Dana Jurkovičová; Ľubica Lacinová
Journal:  Cell Mol Neurobiol       Date:  2016-08-12       Impact factor: 5.046

Review 9.  Fibrosis in the central nervous system: from the meninges to the vasculature.

Authors:  Corey R Fehlberg; Jae K Lee
Journal:  Cell Tissue Res       Date:  2021-06-30       Impact factor: 5.249

10.  The neuroprotective functions of transforming growth factor beta proteins.

Authors:  Arpád Dobolyi; Csilla Vincze; Gabriella Pál; Gábor Lovas
Journal:  Int J Mol Sci       Date:  2012-07-03       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.